These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 23933114)
1. Label-free cell phenotypic assessment of the biased agonism and efficacy of agonists at the endogenous muscarinic M3 receptors. Deng H; Sun H; Fang Y J Pharmacol Toxicol Methods; 2013; 68(3):323-33. PubMed ID: 23933114 [TBL] [Abstract][Full Text] [Related]
2. Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1. Hou T; Shi L; Wang J; Wei L; Qu L; Zhang X; Liang X Pharmacol Res; 2016 Jun; 108():39-45. PubMed ID: 27117668 [TBL] [Abstract][Full Text] [Related]
3. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. Fang Y; Li G; Ferrie AM J Pharmacol Toxicol Methods; 2007; 55(3):314-22. PubMed ID: 17207642 [TBL] [Abstract][Full Text] [Related]
4. Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor. Pronin AN; Wang Q; Slepak VZ Mol Pharmacol; 2017 Nov; 92(5):601-612. PubMed ID: 28893976 [TBL] [Abstract][Full Text] [Related]
5. Full and partial agonists of muscarinic M3 receptors reveal single and oscillatory Ca2+ responses by beta 2-adrenoceptors. Kurian N; Hall CJ; Wilkinson GF; Sullivan M; Tobin AB; Willars GB J Pharmacol Exp Ther; 2009 Aug; 330(2):502-12. PubMed ID: 19420300 [TBL] [Abstract][Full Text] [Related]
6. Probing biochemical mechanisms of action of muscarinic M3 receptor antagonists with label-free whole cell assays. Deng H; Wang C; Su M; Fang Y Anal Chem; 2012 Oct; 84(19):8232-9. PubMed ID: 22954104 [TBL] [Abstract][Full Text] [Related]
7. A 100K well screen for a muscarinic receptor using the Epic label-free system--a reflection on the benefits of the label-free approach to screening seven-transmembrane receptors. Dodgson K; Gedge L; Murray DC; Coldwell M J Recept Signal Transduct Res; 2009; 29(3-4):163-72. PubMed ID: 19624282 [TBL] [Abstract][Full Text] [Related]
8. Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line. Lin AL; Zhu B; Zhang W; Dang H; Zhang BX; Katz MS; Yeh CK Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1454-64. PubMed ID: 18385290 [TBL] [Abstract][Full Text] [Related]
9. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor. Sykes DA; Dowling MR; Charlton SJ Mol Pharmacol; 2009 Sep; 76(3):543-51. PubMed ID: 19498041 [TBL] [Abstract][Full Text] [Related]
10. A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: evidence for differential inverse agonism. Dowling MR; Willets JM; Budd DC; Charlton SJ; Nahorski SR; Challiss RA J Pharmacol Exp Ther; 2006 Jun; 317(3):1134-42. PubMed ID: 16489127 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Heinrich JN; Butera JA; Carrick T; Kramer A; Kowal D; Lock T; Marquis KL; Pausch MH; Popiolek M; Sun SC; Tseng E; Uveges AJ; Mayer SC Eur J Pharmacol; 2009 Mar; 605(1-3):53-6. PubMed ID: 19168056 [TBL] [Abstract][Full Text] [Related]
13. Distinct Agonist Regulation of Muscarinic Acetylcholine M2-M3 Heteromers and Their Corresponding Homomers. Aslanoglou D; Alvarez-Curto E; Marsango S; Milligan G J Biol Chem; 2015 Jun; 290(23):14785-96. PubMed ID: 25918156 [TBL] [Abstract][Full Text] [Related]
14. An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators. Kebig A; Kostenis E; Mohr K; Mohr-Andrä M J Recept Signal Transduct Res; 2009; 29(3-4):140-5. PubMed ID: 19586284 [TBL] [Abstract][Full Text] [Related]
15. Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform. Stewart GD; Sexton PM; Christopoulos A ACS Chem Biol; 2010 Apr; 5(4):365-75. PubMed ID: 20155933 [TBL] [Abstract][Full Text] [Related]
16. Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M3 chimeric G protein-coupled receptor. Zeng FY; McLean AJ; Milligan G; Lerner M; Chalmers DT; Behan DP Mol Pharmacol; 2003 Dec; 64(6):1474-84. PubMed ID: 14645678 [TBL] [Abstract][Full Text] [Related]
17. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor. Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630 [TBL] [Abstract][Full Text] [Related]
18. Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Ehlert FJ; Sawyer GW; Esqueda EE Life Sci; 1999; 64(6-7):387-94. PubMed ID: 10069501 [TBL] [Abstract][Full Text] [Related]
19. Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR). Strachan RT; Sun JP; Rominger DH; Violin JD; Ahn S; Rojas Bie Thomsen A; Zhu X; Kleist A; Costa T; Lefkowitz RJ J Biol Chem; 2014 May; 289(20):14211-24. PubMed ID: 24668815 [TBL] [Abstract][Full Text] [Related]
20. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective. Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]